A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
Mol Cancer Ther
; 6(8): 2158-67, 2007 Aug.
Article
in En
| MEDLINE
| ID: mdl-17671083
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazines
/
Colorectal Neoplasms
/
Signal Transduction
/
Receptor, IGF Type 1
/
Protein Kinase Inhibitors
/
Imidazoles
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2007
Type:
Article
Affiliation country:
United States